91 institutions reported holding $1.46B of AVALYN PHARMA (AVLN) in SEC 13F filings for 2026-06-30. Largest institutional holders: FMR LLC ($192.1M), NOVO HOLDINGS A/S ($127.8M), SR One Capital Management, LP ($108.9M), PERCEPTIVE ADVISORS LLC ($88.1M), SUVRETTA CAPITAL MANAGEMENT, LLC ($82.4M). Source: SEC Form 13F.
来源:SEC 13F 申报文件 · 截至 2026-06-30